Anuh Pharma Share Price

Anuh Pharma Corporate Action

CMP as on19-Aug-22 15:29

₹ 92.60
0.4 0.43%

Open

₹ 92.00

Turnover (lac)

₹ 2

Prev. Close

₹ 92.20

Day's Vol (shares)

₹ 8,516

Day's Range

₹ 91.25
₹ 92.95

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 27-Jul-2022 - -
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday 5th August 2022 inter alia: l) To consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June 2022; and 2) To consider any other matter with the permission of the Chairman. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 5th August, 2022, inter-alia considered and approved the following agenda Items: 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter ended 30th June, 2022. Pursuant to the provisions of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the following: 1. Unaudited Financial Results for the quarter ended June 30, 2022; and 2. Limited Review Report for the quarter ended June 30, 2022. (As per BSE Announcement Dated on 05/08/2022) We would like to inform that the Members of the Company in their meeting held on Friday, August 05, 2022, have considered and approved the request received from few Promoters/ Promoter Group of the Company seeking reclassification of their shareholding from Promoters/ Promoter Group to Public category (the same was recommended by the Board of Directors at its Meeting held on 14th May, 2022). (As Per BSE Announcement Dated on 06/08/2022)
Board Meeting - 07-May-2022 - -
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2022 ,inter alia, to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 14th May, 2022, inter alia: 1) To consider and approve Audited Financial Results of the Company for the quarter & year ended 31st March, 2022; and 2) To consider and recommend Final Dividend, if any, for the financial year 2021-22. Anuh Pharma Ltd. has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on May 14, 2022, inter alia, to consider and approve the audited financial results for the quarter and year ended March 31, 2022 and to consider recommendation of dividend, if any, amongst other routine matters. (As Per BSE Announcement Dated on 07.05.2022) Anuh Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 14, 2022, inter alia has recommended final dividend of Rs. 1.75/- per equity share of face value of Rs. 5/- each (i.e. 35%) for the Financial Year ended March 31, 2022, subject to the approval of the Shareholders at the ensuing Annual General Meeting of the Company. Outcome of Board Meeting held on 14th May 2022 (As Per BSE Announcement dated on 14.05.2022) Please find enclosed herewith the copy of newspaper advertisement with respect to the Audited Financial Results for the quarter and year ended 31 March, 2022, published in the Financial Express and Mumbai Lakshadeep on Sunday, May 15, 2022 in compliance with Regulation 4 7 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement dated on 16.05.2022)
Board Meeting - 25-Jan-2022 - -
ANUH PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2022 inter alia to consider and approve Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday 4th February 2022 inter alia: 1)To consider and approve Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2021; 2)To consider and appoint Mr. Bharat Gangani for the post of Company Secretary & Compliance Officer of the Company; and 3)To consider any other matter with the permission of the Chairman. Pursuant to the provisions of Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Friday, 4th February, 2022, inter-alia considered and approved the following: 1.The Un-audited Financial Results along with Limited Review Report thereon for the quarter and nine months ended December 31, 2021; 2.Appointment of Mr. Bharat Gangani as the Company Secretary & Compliance Officer and designated him as a Key Managerial Personnel of the Company w.e.f. February 04, 2022. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors of the Company at their meeting held on 4th February, 2022, approved the appointment of Mr. Bharat Gangani having Membership no. A51420 w.e.f. 04, February, 2022 as the Company Secretary and Compliance Officer of the Company and shall be designated as the Key Managerial Personnel of the Company. (As Per BSE Announcement Dated on 04.02.2022)
Board Meeting - 21-Jan-2022 - -
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Performance Evaluation Meeting held today i.e. Friday, 21st January, 2022, has noted the resignation of Ms. Ashwini Ambrale, from the post of Company Secretary and Compliance Officer of the Company.
Board Meeting - 01-Nov-2021 - -
Quarterly Results Pursuant to the provisions of Regulation 30 read with Schedule III of the SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company (the Board) at its Meeting held today i.e. Wednesday, 10th November, 2021, inter-alia considered and approved the following: 1. The Un-audited Financial Results along with Limited Review Report thereon for the quarter and half year ended September 30, 2021; 2. The proposal for Direct Listing of Equity Shares of the Company on the Main Board of National Stock Exchange of India Limited (NSE) subject to requisite approvals. (As per BSE Announcement Dated on 10/11/2021) We are submitting herewith the copy of newspaper advertisement with respect to the Unaudited Financial Results for the quarter and half year ended September 30, 2021, published in the Financial Express and Mumbai Lakshadeep on Thursday, November 11, 2021 in compliance with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated 11.11.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity